	title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	characteristics_ch1	treatment_protocol_ch1	growth_protocol_ch1	molecule_ch1	extract_protocol_ch1	label_ch1	label_protocol_ch1	taxid_ch1	hyb_protocol	scan_protocol	description	data_processing	platform_id	contact_name	contact_email	contact_laboratory	contact_department	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	supplementary_file	data_row_count	relation
GSM1507802	ZR751_EpVC_0hr_rep1	GSM1507802	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851198	bioproject id: 252531	time: 0hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507802/GSM1507802_EpVC00n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851198
GSM1507803	ZR751_EpVC_0hr_rep2	GSM1507803	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851199	bioproject id: 252531	time: 0hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507803/GSM1507803_EpVC00n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851199
GSM1507804	ZR751_EpVC_0hr_rep3	GSM1507804	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1:1000 EtOH for 0hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851200	bioproject id: 252531	time: 0hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507804/GSM1507804_EpVC00n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851200
GSM1507805	ZR751_EpE_16hr_rep1	GSM1507805	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851201	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507805/GSM1507805_EpE16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851201
GSM1507806	ZR751_EpE_16hr_rep2	GSM1507806	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851202	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507806/GSM1507806_EpE16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851202
GSM1507807	ZR751_EpE_16hr_rep3	GSM1507807	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851203	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507807/GSM1507807_EpE16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851203
GSM1507808	ZR751_EpEM_16hr_rep1	GSM1507808	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851204	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507808/GSM1507808_EpEM16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851204
GSM1507809	ZR751_EpEM_16hr_rep2	GSM1507809	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851205	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507809/GSM1507809_EpEM16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851205
GSM1507810	ZR751_EpEM_16hr_rep3	GSM1507810	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851206	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507810/GSM1507810_EpEM16n4.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851206
GSM1507811	ZR751_EpEP_16hr_rep1	GSM1507811	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851207	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507811/GSM1507811_EpEP16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851207
GSM1507812	ZR751_EpEP_16hr_rep2	GSM1507812	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851208	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507812/GSM1507812_EpEP16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851208
GSM1507813	ZR751_EpEP_16hr_rep3	GSM1507813	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851209	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507813/GSM1507813_EpEP16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851209
GSM1507814	ZR751_EpEP_16hr_rep4	GSM1507814	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs. Replicate 4.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851210	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507814/GSM1507814_EpEP16n4.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851210
GSM1507815	ZR751_EpEP_16hr_rep5	GSM1507815	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs. Replicate 5.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM estrogen plus 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851211	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507815/GSM1507815_EpEP16n5.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851211
GSM1507816	ZR751_EpM_16hr_rep1	GSM1507816	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851212	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507816/GSM1507816_EpM16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851212
GSM1507817	ZR751_EpM_16hr_rep2	GSM1507817	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851213	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507817/GSM1507817_EpM16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851213
GSM1507818	ZR751_EpM_16hr_rep3	GSM1507818	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851214	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507818/GSM1507818_EpM16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851214
GSM1507819	ZR751_EpM_4hr_rep1	GSM1507819	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851215	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507819/GSM1507819_EpM04n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851215
GSM1507820	ZR751_EpM_4hr_rep2	GSM1507820	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851216	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507820/GSM1507820_EpM04n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851216
GSM1507821	ZR751_EpM_4hr_rep3	GSM1507821	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851217	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507821/GSM1507821_EpM04n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851217
GSM1507822	ZR751_EpM_8hr_rep1	GSM1507822	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851218	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507822/GSM1507822_EpM08n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851218
GSM1507823	ZR751_EpM_8hr_rep2	GSM1507823	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851219	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507823/GSM1507823_EpM08n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851219
GSM1507824	ZR751_EpM_8hr_rep3	GSM1507824	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM medroxyprogesterone acetate for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851220	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507824/GSM1507824_EpM08n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851220
GSM1507825	ZR751_EpP_16hr_rep1	GSM1507825	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851221	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507825/GSM1507825_EpP16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851221
GSM1507826	ZR751_EpP_16hr_rep2	GSM1507826	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851222	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507826/GSM1507826_EpP16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851222
GSM1507827	ZR751_EpP_16hr_rep3	GSM1507827	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851223	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507827/GSM1507827_EpP16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851223
GSM1507828	ZR751_EpP_4hr_rep1	GSM1507828	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851224	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507828/GSM1507828_EpP04n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851224
GSM1507829	ZR751_EpP_4hr_rep2	GSM1507829	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851225	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507829/GSM1507829_EpP04n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851225
GSM1507830	ZR751_EpP_4hr_rep3	GSM1507830	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851226	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507830/GSM1507830_EpP04n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851226
GSM1507831	ZR751_EpP_8hr_rep1	GSM1507831	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851227	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507831/GSM1507831_EpP08n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851227
GSM1507832	ZR751_EpP_8hr_rep2	GSM1507832	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851228	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507832/GSM1507832_EpP08n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851228
GSM1507833	ZR751_EpP_8hr_rep3	GSM1507833	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 10nM progesterone for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851229	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507833/GSM1507833_EpP08n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851229
GSM1507834	ZR751_EpVC_16hr_rep1	GSM1507834	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851230	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507834/GSM1507834_EpVC16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851230
GSM1507835	ZR751_EpVC_16hr_rep2	GSM1507835	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851231	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507835/GSM1507835_EpVC16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851231
GSM1507836	ZR751_EpVC_16hr_rep3	GSM1507836	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851232	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507836/GSM1507836_EpVC16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851232
GSM1507837	ZR751_EpVC_4hr_rep1	GSM1507837	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851233	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507837/GSM1507837_EpVC04n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851233
GSM1507838	ZR751_EpVC_4hr_rep2	GSM1507838	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851234	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507838/GSM1507838_EpVC04n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851234
GSM1507839	ZR751_EpVC_4hr_rep3	GSM1507839	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 4hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851235	bioproject id: 252531	time: 4hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507839/GSM1507839_EpVC04n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851235
GSM1507840	ZR751_EpVC_8hr_rep1	GSM1507840	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs. Replicate 1.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851236	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507840/GSM1507840_EpVC08n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851236
GSM1507841	ZR751_EpVC_8hr_rep2	GSM1507841	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs. Replicate 2.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851237	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507841/GSM1507841_EpVC08n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851237
GSM1507842	ZR751_EpVC_8hr_rep3	GSM1507842	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs. Replicate 3.	Homo sapiens	treatment: cells pretreated with 10nM E2 for 72 hours, overlayed with 1part per million vehicle (ethanol) for 8hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851238	bioproject id: 252531	time: 8hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507842/GSM1507842_EpVC08n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851238
GSM1507843	ZR751_vcvc_16hr_rep1	GSM1507843	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 1.	Homo sapiens	treatment: cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851239	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507843/GSM1507843_vcvc16n1.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851239
GSM1507844	ZR751_vcvc_16hr_rep2	GSM1507844	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 2.	Homo sapiens	treatment: cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851240	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507844/GSM1507844_vcvc16n2.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851240
GSM1507845	ZR751_vcvc_16hr_rep3	GSM1507845	Public on Oct 18 2015	Sep 18 2014	Oct 18 2015	RNA	1	Breast cancer ZR751 cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs. Replicate 3.	Homo sapiens	treatment: cells plated in 1 part per million vehicle (ethanol) for 72 hours, overlayed with 1part per million vehicle (ethanol) for 16hrs	cell line: ZR751	tissue: breast cancer	biosample number: SAMN02851241	bioproject id: 252531	time: 16hrs	Cells were treated using an overlay method involving treatment with 10X concetrated hormone mixture at 1:10 of the cell culture volume, followed by gentle swirling. Treatment times were staggered, and the RNA was isolated as a batch at the culmination of the experiment.	Cells were routinely passaged in RPMI1640 supplemented with 10% FBS. ZR-75-1 cells (passage 16; ATCC) were plated at 500,000 cells/well in 6 well plates in phenol red free RPMI1640 (Life Technologies) supplemented with 10% dextran-charcoal stripped FBS (Hyclone) and treated with hormones as described for each sample. RNA extracted at the timepoints indicated, DNAse treated on column using Qiagen RNeasy kit. An aliquot of each sample was used to synthesise cDNA to validate treatment effects. RNA quality was assessed for each sample via bioanalyser, with an average RIN of  9.6 (range 8.8 to 9.9).	total RNA	Extraction was performed using Qiagen Rneasy kit and on-column Dnase digestion according to manufacturer's instructions.	biotin	Biotinylated cDNA was prepared from 300ng RNA according to standard Affymetrix protocols	9606	Standard Affymetrix hybridisation protocol	Standard Affymetrix scanning protocol	RNA isolation with Qiagen Rneasy kit + Dnase digestion	Raw data was processed in R using bioconductor and Limma. Array data was normalized using RMA	GPL16686	Eleanor,F,Need	eleanor.need@adelaide.edu.au	Cancer Biology Group	Discipline of Surgery	The University of Adelaide	28 Woodville Rd	Woodville South	SA	5011	Australia	ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1507nnn/GSM1507845/GSM1507845_vcvc16n3.CEL.gz	53617	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02851241
